![Case P arr [GRCh37] 17q21.2](https://www.docslides.com/dplay.png)
![Case P arr [GRCh37] 17q21.2](https://thumbs.docslides.com/932836/case-p-arr-grch37-17q21-2-l.jpg)
3952943739545915 x3 mat 10yearold female with hearing loss maternal family history of hearing loss Note These example CNVs have been created for educational purposes in order to ensure that each evidence type in the scoring matrices are utilized across the entire set no single CNV will n ID: 932836
Download Presentation The PPT/PDF document "Case P arr [GRCh37] 17q21.2" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Case Parr[GRCh37] 17q21.2(39529437_39545915) x3 mat
10-year-old female with hearing loss; maternal family history of hearing loss
Note: These example CNVs have been created for educational purposes in order to ensure that each evidence type in the scoring matrices are utilized across the entire set (no single CNV will necessarily cover all evidence types). These are not actual CNVs that have been observed in a laboratory setting. As such, please evaluate the coordinates as given, regardless of other considerations that may apply in the actual clinical laboratory setting. For example, if your CNV is below the size cutoff your laboratory uses on a daily basis, please disregard this for the sake of this exercise and evaluate the content within the provided coordinates. Assume that the CNV is technically valid.
Slide2Clinical Information
arr[GRCh37] 17q21.2(39529437_39545915) x3 mat10-year-old female with hearing lossEstimated prevalence of AR hearing loss: ~1/200Estimated prevalence of AD hearing loss (based on NHANES data in individuals 0-49): ~1/30Maternal family history of hearing lossVariant is maternally inheritedUse the GAIN scoring metric
Oza
et al.
2018, PMID: 30311386
Slide3Section 1: Initial Assessment of Genomic Content
Case P
Gene Involved
Would apply category 1A (contains protein-coding or other known functionally important elements), as this duplication includes a protein-coding gene.
0 points; continue evaluation
Total: 0 points
Slide4Section 2: Overlap with Established TS, HI, or Benign Genes/Genomic Regions
Case P
ClinGen Curated Track = EMPTY
CNV P does not overlap with any current ClinGen curated genes/regions.
Total: 0 points
Slide5Section 3: Evaluation of Gene Number
CNV P contains only a single protein-coding gene,
KRT34
.
Use Category 3A, 0 points
Total: 0 points
Slide6Section 4: Detailed Evaluation of Genomic Content
As of July 2020, KRT34, a hair keratin, has not been associated with human disease per OMIMBasic literature search does not reveal any convincing evidenceThere is a single report of a child with a clinical diagnosis of primary ciliary dyskinesia with a duplication involving KRT34, as well as other CNVs and other variants identified on exome sequencing (PMID:31835165).
Check population data for any additional information.
Slide7Approximate length of CNV P
KRT34
While smaller than CNV P, this duplication does include all of
KRT34.
No other genes are involved in CNV P. What is the frequency of this variant?
Slide8The variant passed quality filters.
A sufficient number of alleles has been studied (>2000 alleles from a continental population).
While this variant has been observed within most of the studied populations, they are the most frequent in Africans, with an allele frequency of 8.8%.
Hearing loss, however, is a relatively frequent condition – how does this particular allele frequency align with estimates of disease prevalence?
Total: -1 points
Slide9ClinGen has a variant curation expert panel (VCEP) focused on Hearing Loss.
The group specified the ACMG/AMP sequence variant interpretation criteria, including those involving population data frequencies, for both AD and AR hearing loss.
As above, variants at greater than 0.005 for AR hearing loss or 0.001 for AD hearing loss can be classified as Benign using the BA1 criteria.
Our variant is more frequent than both of those cutoffs. Apply Category 4O, -1 points.
Oza
et al.
2018, PMID: 30311386
Slide10Similar high frequency duplications are observed in the DGV Gold Standard Dataset
Case P
DGV Gold Standard
Total: -1 points
Slide11Section 5: Evaluation of Inheritance Pattern/Family History for Patient Being Studied
Our patient is a 10-year-old female with hearing loss.Regardless of inheritance information, similar duplications are observed frequently in the general population, at frequencies too high to be a plausible cause for hearing loss.But the variant is maternally inherited! And she has a maternal family history of hearing loss!This does not change the evidence discussed above, or our assessment of the variant. Similar variants are demonstrated to be common in the general population, and children have a 50% chance of inheriting any variant present in their parents.
This variant is most likely a “red herring.”
No positive points should be awarded for inheritance from a family member with consistent phenotype.
Total: -1 points
Slide12ConclusionClassification: Benign
Similar duplications are observed in the general population at frequencies too high to be a plausible cause of hearing loss.Consider additional testing to investigate other potential causes for hearing loss in this individual.